First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial

Journal:

The Lancet Oncology

Published:

2025-09-02

DOI:

10.1016/s1470-2045(25)00343-2

Affiliations:

42

Authors:

42

Go to article

Institutions	Authors	Share
Beijing Cancer Hospital / School of Oncology, PKUHSC, China	3.000000	0.07
Qilu Hospital of Shandong University, China	2.000000	0.05
Cancer Institute and Hospital, CAMS & PUMC, China	2.000000	0.05
The Second Hospital of Dalian Medical University, China	1.000000	0.02
China-Japan Friendship Hospital, China	1.000000	0.02
First Hospital of Lanzhou University, LZU, China	1.000000	0.02
First Affiliated Hospital, SHZU, China	1.000000	0.02
The Second Affiliated Hospital of Chongqing Medical University, CQMU, China	1.000000	0.02
Second Affiliated Hospital, AHMU, China	1.000000	0.02
The First Hospital of Jiaxing, China	1.000000	0.02
West China School of Medicine/West China Hospital of Sichuan University (WCSM/WCH), SCU, China	1.000000	0.02
First Affiliated Hospital of Xinjiang Medical University, China	1.000000	0.02
Tianjin Medical University Cancer Institute and Hospital, TMU, China	1.000000	0.02
Xinjiang Tumor Hospital, XJMU, China	1.000000	0.02
The First Affiliated Hospital of Chongqing Medical University, China	1.000000	0.02
Peking University Third Hospital (PUTH), PKUHSC, China	1.000000	0.02
Tongji Hospital (TJH), HUST, China	1.000000	0.02
The Second Affiliated Hospital of Xi'an Jiaotong University, XJTU, China	1.000000	0.02
The First Affiliated Hospital of Fujian Medical University, China	1.000000	0.02
Xijing Hospital, China	1.000000	0.02
Peking University First Hospital, PKUHSC, China	1.000000	0.02
Jiangxi Provincial Cancer Hospital, China	1.000000	0.02
Peking Union Medical College Hospital (PUMCH), China	1.000000	0.02
Southwest Hospital, Army Medical University, China	1.000000	0.02
Hunan Cancer Hospital, China	1.000000	0.02
The First Hospital of Jilin University, China	1.000000	0.02
Harbin Medical University Cancer Hospital, China	1.000000	0.02
PLA Air Force General Hospital, China	1.000000	0.02
State Key Laboratory of Oncology in South China, SYSUCC, China	1.000000	0.02
Shanghai Tenth People's Hospital, Tongji University, China	1.000000	0.02
Jiangsu Provincial People's Hospital (The First Affiliated Hospital of Nanjing Medical University), China	1.000000	0.02
Liaoning Cancer Hospital and Institute, China	1.000000	0.02
The Second Hospital of Tianjin Medical University, TMU, China	1.000000	0.02
Drum Tower Hospital, China	1.000000	0.02
The First Affiliated Hospital of Nanchang University, China	1.000000	0.02
Fujian Provincial Hospital, China	1.000000	0.02
Chia Tai Tianqing Pharmaceutical Group Co. Ltd., China	1.000000	0.02
Yantai Yuhuangding Hospital, China	0.500000	0.01
Qingdao University (QU), China	0.500000	0.01

Interested in Oncology and Carcinogenesis?